Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HeartVue is a healthcare technology company that develops artificial intelligence solutions for cardiovascular risk assessment. The company's core technology utilizes deep learning to analyze medical imaging, such as chest CT scans, to detect and quantify coronary artery calcification (CAC). By providing automated, opportunistic screening from scans performed for non-cardiac reasons, HeartVue helps clinicians identify patients at high risk for heart disease earlier. The platform is designed to integrate seamlessly into radiology workflows to improve diagnostic accuracy and patient outcomes. HeartVue aims to reduce the global burden of heart disease by making preventative screening more accessible through automation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HeartVue.